Research Analysts’ Price Target Changes for March 18th (BBIO, COHU, CYTK, JBL, LMT, LULU, M, OKLO, QFIN, SYRE)

Research Analysts’ price target changes for Wednesday, March 18th:

BridgeBio Pharma (NASDAQ:BBIO) had its target price increased by Mizuho from $91.00 to $106.00. The firm currently has an outperform rating on the stock.

Cohu (NASDAQ:COHU) had its target price increased by Stifel Nicolaus from $32.00 to $34.00. The firm currently has a buy rating on the stock.

Cytokinetics (NASDAQ:CYTK) had its target price boosted by Mizuho from $84.00 to $100.00. Mizuho currently has an outperform rating on the stock.

Jabil (NYSE:JBL) had its price target increased by Barclays PLC from $283.00 to $304.00. They currently have an overweight rating on the stock.

Lockheed Martin (NYSE:LMT) had its target price increased by Susquehanna from $725.00 to $740.00. Susquehanna currently has a positive rating on the stock.

lululemon athletica (NASDAQ:LULU) had its price target lowered by BNP Paribas Exane from $206.00 to $170.00. BNP Paribas Exane currently has a neutral rating on the stock.

lululemon athletica (NASDAQ:LULU) had its price target lowered by Stifel Nicolaus from $210.00 to $176.00. They currently have a hold rating on the stock.

Macy’s (NYSE:M) had its price target reduced by JPMorgan Chase & Co. from $24.00 to $21.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Oklo (NYSE:OKLO) had its price target trimmed by The Goldman Sachs Group, Inc. from $91.00 to $65.00. They currently have a neutral rating on the stock.

Qfin (NASDAQ:QFIN) had its price target lowered by Jefferies Financial Group Inc. from $30.30 to $23.40. They currently have a buy rating on the stock.

Spyre Therapeutics (NASDAQ:SYRE) had its target price raised by Stifel Nicolaus from $70.00 to $92.00. The firm currently has a buy rating on the stock.

Western Alliance Bancorporation (NYSE:WAL) had its target price cut by Barclays PLC from $105.00 to $90.00. They currently have an overweight rating on the stock.